Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling

Neoplasia

Volumn 13, Issue 9, 2011, Pages 831-840

  Agudelo Garcia, Paula A ^a   de Jesus, Jessica K ^a   Williams, Shante P ^b   Nowicki, Michal O ^b   Chiocca, Ennio Antonio ^b   Liyanarachchi, Sandya ^b   Li, Pui Kai ^a   Lannutti, John J ^c   Johnson, Jed K ^c   Lawler, Sean E ^b,d   Viapiano, Mariano S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c Ohio State University   (United States)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; JANUS KINASE; MOLECULAR SCAFFOLD; MYOSIN II; NANOFIBER; POLYCAPROLACTONE; POLYSTYRENE; STAT PROTEIN; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CCND1 GENE; CELL ADHESION; CELL ELONGATION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; CXCL2 GENE; EXPLANT; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA CELL; HUMAN; HUMAN CELL; IL11 GENE; IL8 GENE; INHIBITION KINETICS; MOUSE; NONHUMAN; PARTICLE SIZE; PIK3CD GENE; PRIORITY JOURNAL; SERPINE1 GENE; SIGNAL TRANSDUCTION; SPHK1 GENE; STRESS FIBER; TISSUE CULTURE; TLP GENE; TOPOGRAPHY; WHITE MATTER;

EID: 80053439903     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11612     Document Type: Article

References (53)

1. Wen PY and Kesari S (2008). Malignant gliomas in adults. N Engl J Med 359, 492-507.
2. Louis DN (2006). Molecular pathology of malignant gliomas. Ann Rev Pathol 1, 97-117.
3. Decaestecker C, Debeir O, Van Ham P, and Kiss R (2007). Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration. Med Res Rev 27, 149-176.
4. Bellail AC, Hunter SB, Brat DJ, Tan C, and Van Meir EG (2004). Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36, 1046-1069.
5. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, and Berens ME (2003). Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116, 4409-4417.
6. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, et al. (2001). Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53, 161-176.
7. Lamszus K, Kunkel P, and Westphal M (2003). Invasion as limitation to antiangiogenic glioma therapy. Acta Neurochir Suppl 88, 169-177.
8. Zhai GG, Malhotra R, Delaney M, Latham D, Nestler U, Zhang M, Mukherjee N, Song Q, Robe P, and Chakravarti A (2006). Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76, 227-237.
9. Viapiano MS and Lawler SE (2009). Glioma invasion: mechanisms and therapeutic challenges. In CNS Cancer: Models, Prognostic Factors and Targets. E Van Meir (Ed). Humana Press, Totowa, NJ. pp. 1219-1252.
10. Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, and Canoll P (2008). The role of myosin II in glioma invasion of the brain. Mol Biol Cell 19, 3357-3368.
11. Johnson J, Nowicki OM, Lee CH, Chiocca AE, Viapiano MS, Lawler SE, and Lannutti JJ (2009). Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Eng Part C 15, 531-540.
12. Farin A, Suzuki SO, Weiker M, Goldman JE, Bruce JN, and Canoll P (2006). Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 53, 799-808.
13. Devarajan E and Huang S (2009). STAT3 as a central regulator of tumor metastases. Curr Mol Med 9, 626-633.
14. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403.
15. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, and Lawler S (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68, 9125-9130.
16. Hu B, Thirtamara-Rajamani KK, Sim H, and Viapiano MS (2009). Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res 7, 1756-1770.
17. Schust J, Sperl B, Hollis A, Mayer TU, and Berg T (2006). Stattic: a smallmolecule inhibitor of STAT3 activation and dimerization. Chem Biol 13, 1235-1242.
18. Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, et al. (2010). A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. Neoplasia 12, 39-50.
19. Hu B, Kong LL, Matthews RT, and Viapiano MS (2008). The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. J Biol Chem 283, 24848-24859.
20. Sim H, Hu B, and Viapiano MS (2009). Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas. J Biol Chem 284, 26547-26556.
21. Wright GW and Simon RM (2003). A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19, 2448-2455.
22. Fraley SI, Feng Y, Krishnamurthy R, Kim DH, Celedon A, Longmore GD, and Wirtz D (2010). A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat Cell Biol 12, 598-604.
23. Ghibaudo M, Trichet L, Le Digabel J, Richert A, Hersen P, and Ladoux B (2009). Substrate topography induces a crossover from 2D to 3D behavior in fibroblast migration. Biophys J 97, 357-368.
24. Oh YM, Kim JK, Choi Y, Choi S, and Yoo JY (2009). Prediction and experimental validation of novel STAT3 target genes in human cancer cells. PLoS One 4, e6911.
25. Jiang K, Krous LC, Knowlton N, Chen Y, Frank MB, Cadwell C, Centola M, and Jarvis JN (2009). Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach. Placenta 30, 806-815.
26. Merchant JL (2008).What lurks beneath: IL-11, via Stat3, promotes inflammationassociated gastric tumorigenesis. J Clin Invest 118, 1628-1631.
27. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, et al. (2010). The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325.
28. Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD, and Sarkaria JN (2005). Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells. Neoplasia 7, 921-929.
29. Yang F, Brown C, Buettner R, Hedvat M, Starr R, Scuto A, Schroeder A, Jensen M, and Jove R (2010). Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3. Mol Cancer Ther 9, 953-962.
30. Senft C, Priester M, Polacin M, Schroder K, Seifert V, Kogel D, and Weissenberger J (2011). Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101, 393-403.
31. Narayana A, Kunnakkat SD, Medabalmi P, Golfinos J, Parker E, Knopp E, Zagzag D, Eagan P, Gruber D, and Gruber ML (2010). Change in pattern of relapse after antiangiogenic therapy in high-grade glioma. Int J Radiat Oncol Biol Phys DOI: 10.1016/j.ijrobp.2010.10.038.
32. Giese A, Bjerkvig R, Berens ME, and Westphal M (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21, 1624-1636.
33. McKee CT, Last J, Russell P, and Murphy CJ (2011). Indentation versus tensile measurements of Young's modulus for soft biological tissues. Tissue Eng Part B Rev 17, 155-164.
34. Balaban NQ, Schwarz US, Riveline D, Goichberg P, Tzur G, Sabanay I, Mahalu D, Safran S, Bershadsky A, Addadi L, et al. (2001). Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates. Nat Cell Biol 3, 466-472.
35. Yeung T, Georges PC, Flanagan LA, Marg B, Ortiz M, Funaki M, Zahir N, Ming W, Weaver V, and Janmey PA (2005). Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 60, 24-34.
36. Suzuki SO and Iwaki T (2005). Dynamic analysis of glioma cells: looking into ''movement phenotypes''. Neuropathology 25, 254-262.
37. Blando JM, Carbajal S, Abel E, Beltran L, Conti C, Fischer S, and DiGiovanni J (2011). Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice. Neoplasia 13, 254-265.
38. Sherry MM, Reeves A, Wu JK, and Cochran BH (2009). STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 27, 2383-2392.
39. Atkinson GP, Nozell SE, and Benveniste ET (2010). NF-κB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10, 575-586.
40. Konnikova L, Kotecki M, Kruger MM, and Cochran BH (2003). Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3, 23.
41. Dasgupta A, Raychaudhuri B, Haqqi T, Prayson R, Van Meir EG, Vogelbaum M, and Haque SJ (2009). Stat3 activation is required for the growth of U87 cellderived tumours in mice. Eur J Cancer 45, 677-684.
42. Li GH, Wei H, Lv SQ, Ji H, and Wang DL (2010). Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Int J Oncol 37, 103-110.
43. Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, et al. (2007). A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 26, 2435-2444.
44. Fuh B, Sobo M, Cen L, Josiah D, Hutzen B, Cisek K, Bhasin D, Regan N, Lin L, Chan C, et al. (2009). LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. Br J Cancer 100, 106-112.
45. de la Iglesia N, Konopka G, Lim KL, Nutt CL, Bromberg JF, Frank DA, Mischel PS, Louis DN, and Bonni A (2008). Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 28, 5870-5878.
46. Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, et al. (2007). Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem 282, 31460-31468.
47. Tong KM, Shieh DC, Chen CP, Tzeng CY, Wang SP, Huang KC, Chiu YC, Fong YC, and Tang CH (2008). Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-κB/p300 binding in human synovial fibroblasts. Cell Signal 20, 1478-1488.
48. Brantley EC and Benveniste EN (2008). Signal transducer and activator of transcription- 3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6, 675-684.
49. Senft C, Polacin M, Priester M, Seifert V, Kogel D, and Weissenberger J (2010). The nontoxic natural compound curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer 10, 491.
50. Debidda M, Wang L, Zang H, Poli V, and Zheng Y (2005). A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem 280, 17275-17285.
51. Salhia B, Hwang JH, Smith CA, Nakada M, Rutka F, Symons M, and Rutka JT (2008). Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas. Cell Motil Cytoskeleton 65, 12-24.
52. Marchesi F, Piemonti L, Mantovani A, and Allavena P (2010). Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis. Cytokine Growth Factor Rev 21, 77-82.
53. Palfi S, Swanson KR, De BS, Chretien F, Oliveira R, Gherardi RK, Kros JM, Peschanski M, and Christov C (2004). Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer 91, 745-752.